"Papanicolaou Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
| Descriptor ID |
D065006
|
| MeSH Number(s) |
E01.370.225.500.384.100.422 E01.370.225.998.054.422 E04.074.422 E05.200.500.384.100.422 E05.200.998.054.422 E05.242.384.100.422
|
| Concept/Terms |
Papanicolaou Test- Papanicolaou Test
- Test, Papanicolaou
- Pap Test
- Test, Pap
- Pap Smear
- Smear, Pap
- Papanicolaou Smear
- Smear, Papanicolaou
|
Below are MeSH descriptors whose meaning is more general than "Papanicolaou Test".
Below are MeSH descriptors whose meaning is more specific than "Papanicolaou Test".
This graph shows the total number of publications written about "Papanicolaou Test" by people in this website by year, and whether "Papanicolaou Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 3 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 2 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papanicolaou Test" by people in Profiles.
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
-
De-implementation of cervical cancer screening before age 21. Prev Med. 2021 12; 153:106815.
-
A population study of screening history and diagnostic outcomes of women with invasive cervical cancer. Cancer Med. 2021 06; 10(12):4127-4137.
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
-
Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone. Acta Cytol. 2021; 65(2):140-149.
-
Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021 Jan 01; 25(1):43-47.
-
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
-
Prevalence of and Factors Associated With Receiving a Pelvic Examination or Pap Testing Under the Age of 21 Years. J Adolesc Health. 2020 10; 67(4):562-568.
-
Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests? Prev Med. 2020 06; 135:106078.